文献速递肝胆胰外科围术期管理与 ERAS

机器人辅助脾切除术治疗巨脾与超巨脾的早期经验

Early experience with robotic splenectomy for massive and supramassive splenomegaly.
PubMed 文献 · Surgery · 2026-04-20

机器人辅助腹腔镜住院时间最短、无再入院、无中转、无死亡,术后并发症率与其他术式相似,但手术时间最长,近期病例已与腹腔镜相当。

要点

  • 机器人辅助腹腔镜脾切除术对巨脾和超巨脾可行,住院时间最短且无中转。
  • 与开腹相比,腹腔镜和机器人辅助均降低住院时间和估计出血量。
  • 机器人辅助术后并发症率与腹腔镜相似,但手术时间最长。

核心结论

  • 机器人辅助腹腔镜脾切除术对巨脾和超巨脾是可行术式,可能让更多外科医生安全实施微创手术。

研究设计与样本

  • 脾脏大小按头尾长度定义:正常小于14 cm,巨脾14至22 cm,超巨脾大于22 cm。

主要发现

  • 与开腹相比,腹腔镜和机器人辅助腹腔镜均降低住院时间和估计出血量。
  • 机器人辅助腹腔镜住院时间最短,无再入院、无中转、无死亡。
  • 与腹腔镜相比,机器人辅助腹腔镜减少手助端口使用,术后并发症率相似。
  • 机器人辅助腹腔镜手术时间最长,但近期病例与腹腔镜相当。

临床怎么用

  • 对巨脾或超巨脾患者,机器人辅助腹腔镜可作为微创脾切除术的可行选择。
  • 机器人辅助可能减少手助端口使用,并降低免疫受损或高危患者开腹手术的并发症风险。

局限性

  • 单中心回顾性设计,机器人辅助腹腔镜样本量仅18例,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Minimally invasive splenectomy has been associated with improved perioperative outcomes compared with open splenectomy, but its application to massive and supramassive spleens has historically been limited. While laparoscopic splenectomy is feasible, the growing adoption of robotic-assisted laparoscopic splenectomy raises questions about its benefits. We hypothesized that robotic-assisted laparoscopic splenectomy would be feasible for massive and supramassive splenomegaly, superior to open splenectomy, and potentially advantageous over laparoscopic splenectomy. METHODS: A single-institution retrospective review was performed of patients undergoing splenectomy from 2012 to 2024. Patients <18 years or with trauma, variceal bleeding, or major concurrent procedures were excluded. Splenic size was defined by craniocaudal length as normal (<14 cm), massive (14-22 cm), or supramassive (>22 cm). Primary endpoints included perioperative complications (Clavien-Dindo) and length of stay. RESULTS: One hundred six patients (81 laparoscopic splenectomy, 18 robotic-assisted laparoscopic splenectomy, and 7 open splenectomy) were included. Compared with open splenectomy, both laparoscopic splenectomy and robotic-assisted laparoscopic splenectomy had a reduced length of stay and estimated blood loss. Robotic-assisted laparoscopic splenectomy was associated with the shortest length of stay, no readmissions, no conversions, and no mortality. Compared with laparoscopic splenectomy, robotic-assisted laparoscopic splenectomy had reduced hand port use. Postoperative complication rates were similar between approaches. Though robotic-assisted laparoscopic splenectomy was associated with the longest operating time, recent cases showed comparable times to laparoscopic splenectomy. CONCLUSION: Robotic-assisted laparoscopic splenectomy represents a feasible approach to splenectomy, even for massive and supramassive spleens. The superior visualization and instrumentation of robotic-assisted laparoscopic splenectomy may afford a larger number of surgeons safe access to minimally invasive approaches, even for these difficult cases, and thereby spare immunocompromised and high-risk patients the morbidity of an open splenectomy.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Ifuku KA, Aldrete A, Chang A, et al. Early experience with robotic splenectomy for massive and supramassive splenomegaly. Surgery. 2026. PMID: 42142414. doi:10.1016/j.surg.2026.110258

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。